According to a new study published in Nature Communications, researchers at the Department of Laboratory Medicine, Karolinska ...
The program has recently become controversial as a number of high-profile advanced approvals were granted only for the drugs ...
A groundbreaking phase one clinical trial explored a novel cell-based immunotherapy for breast cancer. The study focuses on a new treatment approach that aims to harness the body's immune system to ...
Researchers have developed a three-step plan to support those burdened by the intense fear of cancer returning. This plan offers a consistent, streamlined approach to managing recurrence anxiety, ...
“What we found is that there is very high satisfaction with telemedicine that has remained consistent across the years from ...
New research challenges the notion that tumors operate as 'two-speed' entities. Scientists from the University of Cologne and ...
Thermo Fisher's patent activity and acquisition strategy support growth. Find out why TMO stock is poised for continued ...
In a comprehensive Genomic Press Interview, distinguished psychiatrist Professor Peter Falkai suggests promising new ...
ShiraTronics has commenced the pivotal RELIEV-CM2 CLINICAL Study of its implantable neuromodulation therapy, designed for ...
Tribe Clinical Research in Greenville has announced the launch of a new trial for a drug centered around Alzheimer's ...
WW International, Inc. WW stock has shown a remarkable performance in the past three months, outpacing the S&P 500 and the ...